Login
$FBIO
$1.71 -$0.17 (9.04%) Live

$FBIO 8-K/A SEC Filings

Filed On Filing
22 Nov 2016 8-K/A: Financial Statements and Exhibits

The accompanying unaudited pro forma condensed combined financial statements of Fortress Biotech, Inc. (“Fortress”, “FBIO” or the “Company”) are presented to illustrate the estimated effects of the acquisition of a majority equity stake ...

26 Feb 2014 8-K/A: Unregistered Sales of Equity Securities; Departure/Election of Directors or Officers; Compensation +1 more

This RESTRICTED STOCK ISSUANCE AGREEMENT (the “Agreement”) is made and entered into as of February 20, 2014, by and between Coronado Biosciences Inc., a Delaware corporation (the “Company”), and Michael S. Weiss (the “Grantee”).

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support